GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,587.00p
   
  • Change Today:
      3.50p
  • 52 Week High: 1,711.20
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,114.88m
  • Volume: 788,320
  • Market Cap: £65,303m
  • RiskGrade: 129

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 33,754.00 6,221.00 123.90p 17.9 4.5 +4% 80.00p 3.6%
31-Dec-20 34,099.00 6,968.00 115.90p 14.5 n/a -6% 80.00p 4.8%
31-Dec-21 24,696.00 3,599.00 90.56p 22.2 n/a -22% 80.00p 4.0%
31-Dec-22 29,324.00 5,628.00 139.70p 10.3 0.2 +54% 44.00p 3.1%
31-Dec-23 30,328.00 6,064.00 155.10p 9.4 0.9 +11% 42.00p 2.9%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 31,607.48 8,699.70 156.71p 10.1 9.7 +1% 61.00p 0.0%
31-Dec-25 33,531.44 9,662.45 175.23p 9.0 0.8 +12% 65.55p 0.0%
31-Dec-26 35,171.76 10,634.73 191.66p 8.3 0.9 +9% 71.56p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 17.95 9.35 14.85 0.69

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

GSK Market Data

Currency UK Pounds
Share Price 1,587.00p
Change Today 3.50p
% Change 0.22 %
52 Week High 1,711.20
52 Week Low 1,316.00
Volume 788,320
Shares Issued 4,114.88m
Market Cap £65,303m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
78.09% below the market average78.09% below the market average78.09% below the market average78.09% below the market average78.09% below the market average
39.62% below the sector average39.62% below the sector average39.62% below the sector average39.62% below the sector average39.62% below the sector average
Price Trend
20.69% above the market average20.69% above the market average20.69% above the market average20.69% above the market average20.69% above the market average
71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average
Income
44.86% above the market average44.86% above the market average44.86% above the market average44.86% above the market average44.86% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
26.1% below the market average26.1% below the market average26.1% below the market average26.1% below the market average26.1% below the market average
40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average

What The Brokers Say

Strong Buy 8
Buy 5
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 22-Feb-24 16-Nov-23
Paid 11-Apr-24 11-Jan-24
Amount 16.00p 14.00p

Trades for 19-Apr-2024

Time Volume / Share Price
12:31 145 @ 1,587.00p
12:31 365 @ 1,587.00p
12:30 322 @ 1,587.50p
12:30 107 @ 1,587.50p
12:28 63 @ 1,587.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page